Now loading...
ICICI Securities has given a buy call for Akums Drugs & Pharmaceuticals with a target price of Rs 710, citing profitable growth potential. The company aims to boost margins by curbing API division losses and securing new export orders by CY27. Promoters hold a 75.26% stake, with FIIs at 6.36% and DIIs at 6.71%.
Now loading...